With Zero observations
Cadila Healthcare announced that the USFDA inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned subsidiary, located at SEZ, Ahmedabad from 27 January to 4 February 2020. At the end of the inspection, no observation (483) is issued. The site manufactures oncology injectable for the regulated markets.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)